Lipid metabolism disorders contribute to hepatotoxicity of triclosan in mice.
Animals
Anti-Infective Agents, Local
/ toxicity
Chemical and Drug Induced Liver Injury
/ metabolism
Fatty Acids, Nonesterified
/ biosynthesis
Lipid Metabolism
/ drug effects
Lipid Metabolism Disorders
/ metabolism
Lipidomics
Liver
/ drug effects
Male
Mice
Mice, Inbred C57BL
Oxidation-Reduction
Oxidative Stress
Triclosan
/ toxicity
Triglycerides
/ biosynthesis
Up-Regulation
/ drug effects
Free fatty acid
Hepatotoxicity
Lipid metabolism disorder
Lipidomics
Triclosan
Journal
Journal of hazardous materials
ISSN: 1873-3336
Titre abrégé: J Hazard Mater
Pays: Netherlands
ID NLM: 9422688
Informations de publication
Date de publication:
15 02 2020
15 02 2020
Historique:
received:
10
07
2019
revised:
13
09
2019
accepted:
23
09
2019
pubmed:
7
10
2019
medline:
15
12
2020
entrez:
7
10
2019
Statut:
ppublish
Résumé
Previous in vivo exposure studies focused mainly on nuclear receptors involved in hepatotoxicity of triclosan (TCS). As liver plays a vital role in metabolic processes, dysregulations in lipid metabolism have been identified as potential drivers of pathogenesis. Investigation of changes in lipid metabolism might widen our understanding of toxicological effects as well as the underlying mechanism occurring in the liver. In this study, we comprehensively assessed the effect of TCS exposure on hepatic lipid metabolism in mice. Our results showed that TCS induced significant changes in hepatic free fatty acid pool by upregulation of fatty acid uptake and de novo fatty acid synthesis. Besides, hepatic levels of lipids, including acyl carnitine (AcCa), ceramide (Cer), triacylglycerols (TG), phosphatidylcholine (PC), lysophosphatidylcholine (LPC), phosphatidylethanolamine (PE) were also increased, together with upreguation of genes associated to TG synthesis, fatty acid oxidation and inflammation in TCS exposure group. These changes in lipid homeostasis could contribute to membrane instability, lipid accumulation, oxidative stress and inflammation. Our results suggested that TCS exposure could induce hepatic lipid metabolism disorders in mice, which would further contribute to the liver damage effects of TCS.
Identifiants
pubmed: 31586915
pii: S0304-3894(19)31264-6
doi: 10.1016/j.jhazmat.2019.121310
pii:
doi:
Substances chimiques
Anti-Infective Agents, Local
0
Fatty Acids, Nonesterified
0
Triglycerides
0
Triclosan
4NM5039Y5X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
121310Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.